Serum and dietary vitamin D and cardiovascular disease risk in elderly men: A prospective cohort study

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 22, Issue 10, 2012, Pages 856-863

  Messenger, W ^a   Nielson, C M ^a   Li, H ^a   Beer, T ^b   Barrett Connor, E ^c   Stone, K ^d   Shannon, J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

Cardiovascular disease; Epidemiology; Vitamin D

Indexed keywords

VITAMIN D;

AGED; ARTICLE; BLOOD; CORONARY ARTERY DISEASE; DIET; DIET SUPPLEMENTATION; FOLLOW UP; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MALE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; VITAMIN D DEFICIENCY;

AGED; AGED, 80 AND OVER; CORONARY ARTERY DISEASE; DIET; DIETARY SUPPLEMENTS; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84857263339     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2010.10.019     Document Type: Article

References (30)

1. Martins D., Wolf M., Pan D., Zadshir A., Tareen N., Thadhani R., et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007, 167(11):1159-1165.
2. Forman J.P., Giovannucci E., Holmes M.D., Bischoff-Ferrari H.A., Tworoger S.S., Willett W.C., et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007, 49(5):1063-1069.
3. Carbone L.D., Rosenberg E.W., Tolley E.A., Holick M.F., Hughes T.A., Watsky M.A., et al. 25-Hydroxyvitamin D, cholesterol, and ultraviolet irradiation. Metabolism 2008, 57(6):741-748.
4. Reis J.P., von Muhlen D., Miller E.R. Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol 2008, 159(1):41-48.
5. Chiu K.C., Chu A., Go V.L.W., Saad M.F. Hypovitaminosis D is associated with insulin resistance and {beta} cell dysfunction. Am J Clin Nutr 2004, 79(5):820-825.
6. Li Y.C., Qiao G., Uskokovic M., Xiang W., Zheng W., Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 2004, 89-90(1-5):387-392.
7. Muller K., Haahr P.M., Diamant M., Rieneck K., Kharazmi A., Bendtzen K. 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine 1992, 4(6):506-512.
8. Michel G., Gailis A., Jarzebska-Deussen B., Muschen A., Mirmohammadsadegh A., Ruzicka T. 1,25-(OH)2-vitamin D3 and calcipotriol induce IL-10 receptor gene expression in human epidermal cells. Inflamm Res 1997, 46(1):32-34.
9. Lee J.H., O'Keefe J.H., Bell D., Hensrud D.D., Holick M.F. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?. J Am Coll Cardiol 2008, 52(24):1949-1956.
10. Ohsawa M., Koyama T., Yamamoto K., Hirosawa S., Kamei S., Kamiyama R. 1alpha, 25-dihydroxyvitamin D(3) and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL. Circulation 2000, 102(23):2867-2872.
11. Giovannucci E., Liu Y., Hollis B.W., Rimm E.B. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008, 168(11):1174-1180.
12. Kilkkinen A., Knekt P., Aro A., Rissanen H., Marniemi J., Heliovaara M., et al. Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol 2009, 170(8):1032-1039.
13. Marniemi J., Alanen E., Impivaara O., Seppanen R., Hakala P., Rajala T., et al. Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects. Nutr Metab Cardiovasc Dis 2005, 15(3):188-197.
14. Ginde A.A., Scragg R., Schwartz R.S., Camargo C.A. Prospective study of serum 25-hydroxyvitamin d level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 2009.
15. Dobnig H., Pilz S., Scharnagl H., Renner W., Seelhorst U., Wellnitz B., et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008, 168(12):1340-1349.
16. Semba R.D., Houston D.K., Bandinelli S., Sun K., Cherubini A., Cappola A.R., et al. Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr 2009.
17. Wang T.J., Pencina M.J., Booth S.L., Jacques P.F., Ingelsson E., Lanier K., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117(4):503-511.
18. Melamed M.L., Michos E.D., Post W., Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008, 168(15):1629-1637.
19. Hsia J., Heiss G., Ren H., Allison M., Dolan N.C., Greenland P., et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007, 115(7):846-854.
20. Golomb B., Aronoff-Spencer E., Steadman M., Wu W., Yan A. A ray of sunshine for the vitamin D-heart hypothesis. Arch Intern Med 2009, 169(4):416-417.
21. Trivedi D.P., Doll R., Khaw K.T. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003, 326(7387):469.
22. Blank J.B., Cawthon P.M., Carrion-Petersen M.L., Harper L., Johnson J.P., Mitson E., et al. Overview of recruitment for the osteoporotic fractures in men study (MrOS). Contemp Clin Trials 2005, 26(5):557-568.
23. Orwoll E., Blank J.B., Barrett-Connor E., Cauley J., Cummings S., Ensrud K., et al. Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study-a large observational study of the determinants of fracture in older men. Contemp Clin Trials 2005, 26(5):569-585.
24. Washburn R.A., Ficker J.L. Physical Activity Scale for the Elderly (PASE): the relationship with activity measured by a portable accelerometer. J Sports Med Phys Fitness 1999, 39(4):336-340.
25. Block G., Hartman A.M., Naughton D. A reduced dietary questionnaire: development and validation. Epidemiology 1990, 1(1):58-64.
26. Singh R.J., Taylor R.L., Reddy G.S., Grebe S.K. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab 2006, 91(8):3055-3061.
27. Thomas M.K., Lloyd-Jones D.M., Thadhani R.I., Shaw A.C., Deraska D.J., Kitch B.T., et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998, 338(12):777-783.
28. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., Giovannucci E., Dietrich T., Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. Jama 2005, 293(18):2257-2264.
29. Broe K.E., Chen T.C., Weinberg J., Bischoff-Ferrari H.A., Holick M.F., Kiel D.P. A higher dose of vitamin D reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc 2007, 55(2):234-239.
30. Gorham E.D., Garland C.F., Garland F.C., Grant W.B., Mohr S.B., Lipkin M., et al. Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol 2005, 97(1-2):179-194.